Reimbursement

NACDS Praises Sens. Wyden, Crapo for Continued Bipartisan Push to Reform “Pharmaceutical Benefit Manipulation” As Senate Finance Committee releases legislative framework, NACDS emphasizes its Principles of PBM Reform to ensure comprehensive and lasting solutions for patients, pharmacies, employers, taxpayers, communities, and the nation

admin2023-04-20T09:59:23-04:00Categories: Press Release|Tags: Congress, DIR, PBM, Reimbursement|

As Senate Finance Committee releases legislative framework, NACDS emphasizes its Principles of PBM Reform to ensure comprehensive and lasting solutions for patients, pharmacies, employers, taxpayers, communities, and the nation.

NACDS Lauds Senate Introduction of ‘Drug Pricing Transparency in Medicaid Act’ Bipartisan – now bicameral – legislation is an important part of a comprehensive approach to stopping PBMs’ “pharmaceutical benefit manipulation”

admin2023-04-03T14:40:45-04:00Categories: Press Release|Tags: Congress, Medicaid, PBM, Reimbursement|

NACDS is lauding legislation introduced by U.S. Senators Peter Welch (D-VT) and Roger Marshall (R-KS) to crack down on tactics by which “pharmaceutical benefit manipulator” middlemen maximize profits at the expense of patients, pharmacies, and others.

NACDS Lauds New York’s Medicaid “Promise Kept” NYRx puts patients over PBMs in the state’s Medicaid pharmacy benefit

admin2023-04-03T12:14:27-04:00Categories: In Case You Missed It, Press Release|Tags: Medicaid, PBM, Reimbursement, States|

NYRx puts patients over PBMs in the state’s Medicaid pharmacy benefit.

NACDS Urges Transparency, Accountability, and Fair Competition as Senate Finance Explores PBMs’ Impact on Healthcare Statement defines specific solutions for patient-manipulation by “PBMs” and urges continued bipartisan work on this critical issue

admin2023-03-30T10:11:58-04:00Categories: Press Release|Tags: Congress, DIR, PBM, Pharmacy Value, Reimbursement|

Statement defines specific solutions for patient-manipulation by “PBMs” and urges continued bipartisan work on this critical issue.

In Case You Missed It: HHS Secretary Xavier Becerra Talks ‘Clever’ PBM Middlemen Tactics During Senate Hearing

admin2023-03-29T17:38:36-04:00Categories: In Case You Missed It|Tags: Congress, DIR, PBM, Reimbursement|

Last week, Health and Human Services (HHS) Secretary Xavier Becerra appeared before the U.S. Senate Appropriations Committee to provide testimony on the FY 2024 Funding Request and Budget Justification of the Department of Health and Human Services.

NACDS Applauds House Introduction of Bipartisan Legislation Helping to Preserve Medicare Pharmacy Access 96 percent of those 65 and older say it is “very easy” or “somewhat easy” to access pharmacies – making them the most accessible healthcare destination tested in a national poll

admin2023-03-24T13:17:58-04:00Categories: Press Release|Tags: Congress, Medicare, Pharmacy_Value, Preparedness, Reimbursement, Vaccinations|

96 percent of those 65 and older say it is “very easy” or “somewhat easy” to access pharmacies – making them the most accessible healthcare destination tested in a national poll.

NACDS Praises Continued Focus and Diligence on PBM Reform as Senate Commerce Committee Advances Bill

admin2023-03-22T15:02:07-04:00Categories: Press Release|Tags: Congress, DIR, Reimbursement|

NACDS President and Chief Executive Officer Steven C. Anderson issued the following statement today upon passage of the Pharmacy Benefit Manager Transparency Act (S. 127) by the U.S. Senate Commerce, Science, and Transportation Committee:

NACDS Urges PBM Reform, Medicare Pharmacy Services, and PREP Act Extension as Senate Committee Explores Healthcare Workforce Topics Announces updated national, state, and Congressional District polling relevant to priority issues

admin2023-03-21T15:36:51-04:00Categories: Press Release|Tags: Congress, DIR, Medicare, Preparedness, Reimbursement, Vaccinations|

Announces updated national, state, and Congressional District polling relevant to priority issues.

NACDS Backs Rep. Carter’s Drug Price Transparency in Medicaid Act Says bill is part of bipartisan and comprehensive approach that is emerging to stop “pharmaceutical benefit manipulation” and to put patients over PBM profits

admin2023-12-12T11:11:16-05:00Categories: Press Release|Tags: Congress, Medicaid, PBM, Reimbursement|

The Drug Price Transparency in Medicaid Act will protect patients, pharmacies, and others from middlemen tactics that drive up prescription drug prices.

NACDS Statement in Response to Introduction of PBM Reform Legislation in Florida

admin2023-03-06T16:55:57-05:00Categories: Press Release|Tags: DIR, PBM, Reimbursement, States|

NACDS President and CEO Steven C. Anderson released the following statement today following the introduction of pharmacy benefit manager (PBM) reform legislation (HB 1509/SB 1550) in the Florida legislature:

National Association of Chain Drug StoresPharmacies. The face of neighborhood healthcare.